Sponsorship and Exhibition

Find below the different sponsorship options:

Main sponsor
Specific sponsorship opportunities
Scientific sessions
Book a booth online
Exhibition Manual

Exhibition - The exhibition will be located in the same main hall of Coffee break, Lunch, Poster presentations and Wifi hot area. Therefore, the best possible interaction with the conference participants is expected.

Special Sponsor:

The abstracts were published in Toxicology Letter (Volume 196, Supplement (2010), partly granted by the "Ministerio de Ciencia e Innovación" of the Spanish Goverment
 

Diamond Sponsors

EXPOQUIMIA -BARCELONA
Link to the exhibition for the chemical industry of the future

From Fira Barcelona will hold the most important appointment of applied chemistry in Europe during 2011. Expoquimia, concentrated more than 1100 direct exhibitors and 55.000 of professional visitors. Lab&Bio, as a sector of Expoquimia, is once again shining a spotlight on the companies that specialise in biotechnology and analytical instrumentation, two disciplines that are experiencing unprecedented growth. This dedicated area is where science, knowledge and business come together in support of one of the fastest-growing markets. Innovation and science at the service of industry.
In November 2011 (14-18th) thanks to all of you, we will transform Barcelona in the European Scientific Capital in south europe.

BO HOLMSTEDT MEMORIAL FUND (BMHF)
Link-EUROTOX

Professor Bo Holmstedt was a prominent toxicologist both nationally and internationally, well-known in the toxicology community for his outstanding research, engagement in education, contributions to toxicological organisations and role as a leading authority in toxicological evaluation. He was born 1918 in the southern part of Sweden, and studied medicine at the Karolinska Institute.  In 1952, he graduated with a MD PhD in pharmacology, and became a full professor in toxicology at the Karolinska Institute in 1964.

To honour Professor Bo Holmstedt, the BHMF, in collaboration with EUROTOX, has established the Bo Holmstedt Memorial Lecture to be presented to an outstanding European Toxicologist at the EUROTOX Annual Congress meeting. The foundation is also supporting the Paracelcus symposium at the animal meeting. Bo Holmstedt's great interest in the teaching of toxicology and supported research in developing countries, a travelling lecture fellowship has also been established to allow a toxicologist from a developing country to spent some time in a European laboratory or regulatory agency.

Gold Sponsor

PROUS INSTITUTE FOR BIOMEDICAL RESEARCH
Parc Científic de Barcelona, Torre I Planta 7ª
C/ Baldiri i Reixac, 4-6
08028 Barcelona
Spain
Telf: +34 934 571 795
info@prousresearch.com
www.prousresearch.com

Prous Institute for Biomedical Research is a research company comprised actively involved in drug discovery and the development of in silico technologies. Prous Institute is committed to discovering novel therapies through its Epistemic Drug Discovery Program ® (EDD). Prous Institute's in silico technologies include chemoinformatic prediction technologies used for regulatory and industry safety screening programs and to speed up the process of drug discovery and development. Prous Instiute presents BioEpisteme®
, a quantitative structure-activity relationship (QSAR) software program that facilitates the creation of a wide variety of predictive models, including mechanisms of action, adverse events and toxicological endpoints.

TNO
Utrechtseweg 48
3704 HE ZEIST
The Netherlands
P: +31 30 694 42 73
info-chemistry@tno.nl
www.tno.nl/chemistry

When looking for a facility to professionally perform your toxicology and analytical chemistry studies, contact TNO.
TNO would be a partner not just to perform the studies, but to also discuss the choice of studies, their lay-out and the possibility and availability of alternatives.
Challenge us by discussing your intended program with us.

For more information, please contact us: www.TNO.NL

Silver Sponsors

ACT (American College of Toxicology)

The mission of the American College of Toxicology (A.C.T) is to educate, lead and serve professionals in industry, government and academia by promoting the exchange of information and perspectives on safety assessment and the application of new developments related to toxicology.  A.C.T.’s strategic objectives include focusing on the interdisciplinary exchange of scientific information, sponsoring scientific and educational programs, presenting the ideals of its membership, disseminating information through its journal and newsletter, and serving in other capacities in which the College can function more efficiently as a group than as individuals.

ASTRAZENECA

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. AstraZeneca employs over 62,000 people (47% in Europe, 31% in the Americas and 22% in Asia, Africa and Australasia), and with over 11,000 people in its R&D organization, invests over $4 billion in R&D each year.

FERRER GRUPO

NIEHS (National Institute of Environmental Health Sciences)

The National Institute of Environmental Health Sciences (NIEHS) is one of 27 research institutes and centers that comprise the National Institutes of Health (NIH). The mission of the NIEHS is to reduce the burden of human illness and disability by understanding how the environment influences the development and progression of human disease.
Since its establishment in 1966, NIEHS has evolved to its present status as a world leader in environmental health sciences, with an impressive record of important scientific accomplishments and a proud history of institutional achievements and growth.

RICERCA Biosciences
7528 Auburn Road
Concord, OH  44077
www.ricerca.com
info@ricerca.com

Ricerca Biosciences offers a comprehensive suite of discovery and preclinical services to support drug candidates from discovery through IND on a global scale, including capabilities in discovery and medicinal chemistry, API process chemistry, cGMP manufacturing and scale-up, IND-enabling toxicology, molecular profiling, pharmacology/DMPK and drug safety assessment services. With facilities in Concord, Ohio; Bothell, Washington; Taipei, Taiwan; and Lyon, France, Ricerca offers scientific excellence through reliable, cost-effective strategies to accelerate your drug discovery programs.

SOT (Society of Toxicology USA)
1821 Michael Faraday Drive, Suite 300
Reston, VA 20190 USA
T:703.438-3115 F:703.438-3113
E-Mail: sothq@toxicology.org
Web site: www.toxicology.org

The Society of Toxicology (SOT) is the largest association of professional toxicologists in the world, with over 6500 members from more than 50 countries.  Each year in March, the SOT holds an Annual Meeting and exposition that is attended by 6,000-7,000 scientists, features presentation of over 2400+ abstracts in a variety of session types, and showcases 400 exhibits of products and services.  Members receive discounted registration fees for SOT meetings and the SOT journal, Toxicological Sciences, the premier peer-reviewed, hypothesis-driven publication of original research articles in toxicology.  Stop by the booth to meet SOT leaders, get an update on plans for  the SOT’s 50th Anniversary Meeting March 6-10, 2011 in Washington, DC, and learn about new programs for scientists from developing countries.

Bronze Sponsors

ALMIRALL S.A
General Mitre 151
08022 Barcelona
Spain
www.almirall.com
comercial@almirall.com

About Almirall

Almirall, an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people’s health and wellbeing.    

The therapeutic areas on which Almirall focuses its research resources are related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), rheumatoid arthritis, multiple sclerosis, psoriasis and other dermatological conditions.

Almirall’s products are currently present in over 70 countries while it has direct presence in Europe and Latin America through 11 affiliates.

For further information please visit the website at: www.almirall.com


BIOGEN IDEC

GSK

JAPANESE SOT (JSOC)

The Japanese Society of Toxicology (JSOT) was first organized in 1975 by an ancestral study group, and has just hosted its 37th Annual Meeting in Okinawa. The members from academia, industrial and regulatory sectors, now add up to over 2,500. JSOT issues the Journal of Toxicological Sciences, runs the accreditation board Diplomate of the Japanese Society of Toxicology (D.J.S.T.), and comprises an important part of the toxicology society in Japan with the Japanese Society of Clinical Toxicology and the Japanese Society of Toxicologic Pathology. JSOT is a member of IUTOX and ASIATOX, and will host the ASIATOX-VI meeting in 2012 at Sendai.

PFIZER LIMITED

SANOFI PASTEUR

TARGACEPT

Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, a unique class of proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s lead program, TC-5214, is in Phase 3 development as an adjunct treatment for major depressive disorder. Targacept leverages its scientific leadership and proprietary drug discovery platform Pentad™ to generate novel small molecule product candidates to fuel its pipeline, and uses its expertise to create significant alliances with global pharmaceutical companies. Targacept is committed to Building Health and Restoring Independence™ for patients. For more information, please visit www.targacept.com

Platinium

MINISTERIO DE CIENCIA E INNOVACIÓN

Contributors

ABBOTT LABORATORIES

AFFYMETRIX

ATS

CEETOX

EXXONMOBIL

JOHNSON & JOHNSON PHARMA R & D

GRADIENT CORPORATION

PROCTOR & GAMBLE

PFIZER Global Research and Development

WILEY-BLACKWELL

Sponsors of some specific scientific symposia and workshops {see scientific program}

BASF

RTC

ROCHE DIADNOSTIC

LRI/CEFIC

ILSI/HESIu

Exhibitors

AAALAC INTERNATIONAL

Apartado de Correos 266, 31080 Pamplona, Spain
www.aaalac.org
accredit@aaalac.org  ;  jguillen@aaalac.org
Contact: Javier Guillen. Senior Director and Director of European Activities.

AAALAC International is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. AAALAC stands for the "Association for Assessment and Accreditation of Laboratory Animal Care."
More than 800 companies, universities, hospitals, government agencies and other research institutions in 32 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use.

ACCELERA
Accelera Srl
Viale Pasteur 10
Nerviano, Milano, Italy
www.accelera.org
info@accelera.org

Accelera is a premium tier CRO, working & collaborating with pharmaceutical & biotech companies around the world. From our unique history Accelera offers a unique range of integrated and tailored drug discovery & development services:

• Full IND-enabling packages
• Regulatory Toxicology (including NHP)
• Biologics and Biomarkers
• Safety Pharmacology
• ADME/PK
• Preclinical and Clinical bioanalysis
• HTP Preclinical Profiling
• Regulatory Consultancy

Accelera is uniquely able to provide mainstream pharma capabilities and experience in response to your preclinical development needs, adding value to your products, reducing late attrition rates and improving cycle times.
With Accelera, experience results.

ADVANCELL
Baldiri Reixac, 10-12
Barcelona
Spain
www.advancell.net
advancell@advancell.net

Advancell is a biotechnology company with its own technology and continuous innovation; it délas with unresolved question in Elath and wellbeing using value adding, efficient products and services.
The Company is organized into three business Units:
Alternative Testing, which develops cell in vitro models to predict safety, efficacy and mechanism of action of melecules in development.
Nanosystems, uses natural polymer nanosystems to improve the delivery and administration of drugs and modulate their bioavailability.
Therapeutics, which focuses its activity on developing innovative drugs through development strategies that will enable them to reach the clinical stage efficiently, result-oriented in the search for new applications.

ALERE INTERNATIONAL
Rue des Vignerons 1A
1110 Morges
Switzerland
Tel: 0041 21 80 4 71 40
professionaldiagnostics@alere.com
www.alere.com

Inverness Medical’s new global brand
We are a world leader in diagnostic products to assist laboratory and healthcare professionals in both preventative and interventional medicine, providing qualitative and quantitative results. Our focus is in the broad clinical fields of Women’s Health, Oncology, Infectious Disease Cardiology and Drugs of Abuse.
Alere’s Drug of Abuse portfolio includes an expanding range of rapid tests for urine, oral fluid specimen and solid samples for hospital, laboratories, and point of care units or health centers, workplaces, government and criminal justice; from single testing to almost 20 drugs including sophisticated automatic readers.

BIONAS GmbH
Friedrich-Barnewtitz-Straße 3
18119 Rostock
Germany
www.bionas.de
info@bionas.de

Bionas® specializes in instruments and services for label-free, cell-based assays.
The B2500 analyzing system is a 6 channel system for the simultaneous monitoring of oxygen consumption, acidification and cellular impedance/adhesion. The instrument generates real-time data about the metabolic activity of cells, including regeneration effects. Adherent, primary or suspension cells can be analyzed for applications in toxicology, oncology, drug discovery. 
The B9600 adcon reader is a versatile instrument for label-free monitoring of cellular impedance in 96 well format. It provides real-time information about cell adhesion, proliferation, morphology etc. for high-throughput screening and laboratory research. GLP laboratory service is also available.

BIOBIDE S.L.
Parque Tecnológico de San Sebastián,
Paseo Mikeletegi 58, bajo
San Sebastián 20009
Spain

Biobide is a biotech company that aims to help our customers worldwide developing solutions to face their problems in the Drug Discovery process, integrating zebrafish animal model with innovative tools as High Content Screening based on our automation capability adding value to their R+D+i in the preclinical area.
Biobide helps companies decreasing withdrawals in the Drug Discovery and Development process, saving cost and time obtaining higher revenues from their investment. We are able to set up customized zebrafish toxicity, safety and efficacy assays, to ensure investing in the most successful drug candidates, due to their efficacy or safety.

BIOVENDOR
Laboratorni Medicina a.s. established its Research and Diagnostic Products Division as an emerging innovative biotech company in the Czech Republic in 1995.

Our mission is to provide researchers and medical experts with top-quality immunodiagnostics and related biochemicals – monoclonal and polyclonal antibodies and recombinant proteins. BioVendor has become internationally recognized for its achievements in rapid launching of high-quality products – resulting in the development of biomarkers for early detection of obesity and obesity-related diseases associated with postindustrial societies. Our customers include the world’s top-ranking scientific institutions, pharmaceutical and biotech companies and clinical laboratories throughout more than 60 countries.

BIOPORTO DIAGNOSTICS, A/S
Grusbakken, 8
2820 Gentofte
Denmark
Tel: +45 4529 0000
FAX: +45 4529 0001
www.bioporto.com
www.ngal.com
info@bioporto.com

The primary focus for BioPorto Diagnostics is the new acute kidney injury marker, NGAL. NGAL is a biomarker that allows the early detection of kidney injury in drug safety studies in many animal models.
BioPorto Diagnostics offers a wide selection of NGAL antibodies and ELISA kits for laboratory animals that can be used in all phases of pharmaceutical development and basic research.
BioPorto Diagnostics’ product portfolio covers NGAL measurement in human, rat, mouse, monkey, dog and pig models - providing essential tools to study compound nephrotoxicity and drug safety in the pharmaceutical industry.

CHARLES RIVER
Tranent
EH33 2NE
UK
Tel: + 44 1875 614545
info@eur.crl.com
www.criver.com | accelerating drug development. exactly.

Focused on helping its global partners accelerate their research and drug development efforts, Charles River has provided high-quality research models and laboratory animal support expertise for more than 60 years, with an expanding portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Our unique portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing flexible, customized approaches to support both single-study or broad-based programs.

CIT
BP563
27005 Evreux
France
info@citox.com
www.citox.com

CIT is a leading European CRO specialised in pre-clinical and safety evaluation studies, located just one hour from Paris. Founded 40 years ago CIT works actively with pharmaceutical, biotech, chemical and agrochemical companies for product registrations and notifications.
CIT offers a full range of services: general toxicology in rodents and non-rodents including NHP, DART, carcinogenicity and safety pharmacology, genomics, genetic toxicology TCR/Immunhistochemistry, pharmacokinetics/DMPK and regulatory affairs.
With high quality and ethical standards CIT is fully GLP-compliant and is AAALAC accredited.
Our 350-staff team includes 50 postgraduate scientists (DVM, PharmD, PhD) and is ready to help your upcoming developments.

CULTEX LABORATORIES GMBH
Feodor-Lynen-Str. 21
30625 Hannover
Germany
www.cultex-laboratories.com
info@cultex-laboratories.com

In the field of inhalation toxicology Cultex Laboratories GmbH is the platform for the in vitro analysis of airborne substances, such as particles, gases, volatile compounds and complex gas mixtures under realistic (in- and outdoor) atmospheric conditions. We developed a wide range of commercial available exposure systems, like the CULTEX® RFS module, especially designed for the direct exposure of cultivated cells to test atmospheres. Furthermore, we accept research and development contracts from the industrial as well as the public sector. Our consulting and planning services support both project planning and implementation.

CXR BIOSCIENCES

www.cxrbiosciences.com
audreyvardy@cxrbiosciences.com, jillianmcewan@cxrbiosciences.com

Summary information: CXR Biosciences Ltd. is commercialising innovative approaches to transform the drug development and chemical safety assessment process. As well as developing proprietary technology platforms such as stem cells and humanised mice, CXR also helps customers to take their candidate compounds through development efficiently, or to resolve problems that have been encountered, through the provision of customised solutions. The company has business relationships with many of the world’s leading pharmaceutical companies, chemical companies, biotechnology companies, universities and research institutions. CXR Biosciences Ltd. is located in Dundee, Scotland, UK.

ELLEGAARD GÖTTINGEN MINIPIGS A/S
Soroe Landevej 302
4261 Dalmose
Denmark

Göttingen minipigs ® are accepted non-rodent models in pharmacology and toxicology. Studies performed on these minipigs are fully recognized by regulatory authorities worldwide, including FDA.
They should be considered, along with dogs and primates, when choosing the best non-rodent species for drug development and regulatory studies.

ELSEVIER
Radarweg 29, 1043
NX Amsterdam
Name contact address J. Grondman-de Rijk,
Website: www.elsevier.com
e-mail j.grondmanderijk@elsevier.com

Visit booth number 29 and 30 to explore Elsevier’s high-quality journals and important new books. Elsevier’s toxicology journal programme includes prestigious journals such as Toxicology, Toxicology and Applied Pharmacology, Toxicology Letters, Toxicology in Vitro, Food and Chemical Toxicology, plus many more. Our toxicology publications include the recently published Comprehensive Toxicology, edited by Charlene McQueen, Handbook of Pesticide Toxicology, edited by Robert Krieger, Fundamentals of Toxicologic Pathology, edited by Wanda Haschek and Information Resources in Toxicology, edited by P.J. Hakkinen. Stop by and discover where the most cutting-edge research is published.

EUROPEAN COMMISSION
Dr Tuomo Karjalainen
Research Directorate-General
B-1049 Brussels
Belgium

http://ec.europa.eu/research/environment/index_en.cfm
tuomo.karjalainen@ec.europa.eu

Over two-hundred multidisciplinary pan-European research projects dealing with environment and health issues have been funded by the European Commission’s Research Directorate-General since the beginning of the Fifth Framework Programme of Research in 1998. From the first three calls of the currently running Seventh Framework Programme (2006-2013) over 70 projects have already been selected for funding. The aim of the Commission's participation in the IUTOX event is to provide an information platform for showcasing what kind of research has been funded (including a large number of projects on toxicology) and what kinds of opportunities exist for participation in EU-funded research activities.

EUROPEAN FOOD SAFETY AUTHORITY (EFSA)
Largo N. Palli, 5/a
43121 Parma (Italy)
www.efsa.europa.eu
http://www.efsa.europa.eu/en/contact/askefsa.htm 

The European Food Safety Authority (EFSA) is the keystone of European Union (EU) risk assessment regarding food and feed safety. In close collaboration with national authorities and in open consultation with its stakeholders, EFSA provides independent scientific advice and clear communication on existing and emerging risks. One of the areas in which EFSA advises risk managers at the EU and national level is contaminants in the food chain and undesirable substances such as natural toxicants, mycotoxins and residues of unauthorised substances.

EVOTEC

Two delegates: Dr Adrian Hill and Dr Heike Diekmann
114 Milton Park, Abingdon,
Oxfordshire, OX14 4SA, UK
www.evotec.com
info@evotec.com
adrian.hill@evotec.com - heike.diekmann@evotec.com

Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and Asia. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology and inflammation. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and  Roche.

EXPOQUIMIA

International Chemistry Trade Show
From Fira Barcelona will hold the most important appoiment of applied chemistry in Europe during 2011.
Expoquimia, concentrated more than 1100 direct exhibitors and 55.000 of professional visitors.
Lab&Bio, as a sector of Expoquimia, is once again shining a spotlight on the companies that specialise in biotechnology and analytical instrumentation, two disciplines that are experiencing unprecedented growth. This dedicated area is where science, knowledge and business come together in support of one of the fastest-growing markets. Innovation and science at the service of industry.
In November 2011 (14-18th) thanks to all of you, we will transform Barcelona in the European Scientific Capital in south europe.


EXPUB, a Division of EBSCO Publishing
10 Estes Street
Ipswich, MA 01938
www.expub.com
information@ebscohost.com

Expert Publishing (ExPub) is the premier provider of up-to-date, decision-support chemical information for the global environmental health & safety community. ExPub databases provide access to millions of documents containing comprehensive human and/or environmental hazard data needed to manage the impact of chemicals in the workplace or on the environment. ExPub provides more than 120 databases containing millions of documents from government and licensed sources covering more than 400,000 unique substances and accessible via 2.25 million chemical names and synonyms. Databases include: ChemEXPERT™, ReproEXPERT™, ListEXPERT™, DrugEXPERT™, and MSDSonline®.

GENTRONIX LTD 
CTF BUILDING, GRAFTON STREET, MANCHESTER, M13 9NT, UK 
WWW.GENTRONIX.CO.UK 
paul.docherty@gentronix.co.uk 

Gentronix provides preclinical services and solutions that help companies reduce attrition rates and ensure safer products in the pharma, biotech, cosmetics, agrochemical, FFTE, biomaterial and tobacco industry.
Our specialist CRO facility provides out-sourced services for a wide range ADME and predicitive toxicity endpoints.
A particular focus is on providing better hazard identification assays for genotoxicity through the use of our patented human cell GADD45a reporter assays (GreenScreen® HC and Bluescreen HC) and additional in vitro genotoxicity assays.
Currently over 85 companies in 15 countries are using our assays as part of their preclinical testing strategy.

HARLAN LABORATORIES Ltd.
Zelgliweg 1
4452 Itingen, Switzerland
crs.ch@harlan.com
www.harlan.com

Harlan Laboratories is a leading global provider of essential non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as to academic and government research organizations.　Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. Our mission is helping you do research better.


HUNTIGDON LIFE SCIENCES
Huntingdon Life Sciences
Woolley Road
Alconbury
Huntingdon
Cambs
PE28 4HS

www.huntingdon.com
sales@ukorg.huntingdon.com

Huntingdon Life Sciences, one of the world’s largest non-clinical CROs providing a comprehensive range of services supporting the biopharmaceutical, pharmaceutical, industrial chemical and agrochemical industries.  With large testing facilities in the UK and the USA, we provide timely, efficient, high quality product development solutions to the changing needs of the market.
We offer fully integrated development programmes or stand alone services such as toxicology, safety pharmacology, drug metabolism, bioanalytical services, biomarkers, regulatory affairs, early clinical support, pharmaceutical stability testing,
We are one of the world’s leading CROs in respiratory safety assessment and non-clinical biologics safety testing and infusion technologies. www.huntingdon.com

The International Life Sciences Institute – European branch (ILSI Europe) is a non-profit, worldwide foundation with the aim to advance the understanding of scientific issues relating to nutrition, food safety, toxicology, risk assessment and the environment by bringing together scientists from academia, government, industry and the general public through the advancement of science.

Tel: +44 (0) 1785 825600
Fax: +44 (0) 1785 825625
Email: info@instem.com
Web: www.instem.com

Instem™ is a leading provider of pre-clinical IT solutions to the Life Sciences. Instem™ offers Provantis™, a fully integrated tox/path software solution.  Provantis enables data to be collected, analysed and shared across an organisation of any size, at any stage of a study, from compound receipt through to final report production. From single-users to full-function global toxicology/pathology laboratories, Provantis™ serves organisations of all sizes with on-site or Software as a Service (SaaS) solutions.
Visit booth 17 to see why Provantis is the most flexible, cost-effective and value-added solution on the market.

INSTITUTE FOR IN VITRO SCIENCES
30 West Watkins Mill Road, Suite 100
Gaithersburg, MD, USA 20878
www.iivs.org
info@iivs.org

The Institute for In Vitro Sciences, (IIVS) is a non-profit organization wholly dedicated to the advancement of alternative testing methods. Rigorous scientific and compliance programs coupled with Education and Outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing. This foundation provides a unique forum in which our customers, contributors, regulatory agencies and animal protection organizations can work collaboratively to advance science and animal welfare.

Assays are conducted under GLP (Good Laboratory Practices) conditions and according to FDA, EPA, OECD, and other guidelines. In vitro assays are performed by the IIVS laboratory in the following research areas: Ocular and Dermal Irritation, Phototoxicity, Dermal Corrosivity, Biological Activity Studies, Acute Systemic Toxicity, and Specialized Investigations.  Specialized and/or custom made protocols may be prepared to fit the needs of your study. Please visit us at booth 57 to learn more about activities at IIVS.

JAI RESEARCH FOUNDATION (JRF)
The Global Pre-Clinical CRO, committed to Quality, Safety, Environment & Customer Service.
JRF has endorsement of compliance with the OECD principles of GLP from the GLP monitoring Authority of The Netherlands. AAALAC accreditation.
Our specialization includes

1. Mammalian Toxicology by various routes
   • Subacute to Carcinogenicity
     
   • Developmental toxicity
     
   • Neurotoxicity
     
   • Immunotoxicity
     
   • In-vivo Toxicokinetics/ADME, in Rodents & Non-rodents.
     
   • Endocrine Disruptors under Validation
     
2. In-vitro & In-vivo Genotox.
3. Preliminary & Higher tier Ecotox and E-fate studies
4. Full product characterization
5. Development and validation of analytical methods for a.i.’s, impurities & metabolites in variety of matrices.
6. Regulatory Consultancy.

LAB RESEARCH
LAB Research is a leading preclinical service company offering a wide range of drug development services across a global network.  Our services include:  

• General Toxicology
  
• Infusion Toxicology
  
• Inhalation Toxicology
  
• Minipigs
  
• Primates
  
• Safety Pharmacology
  
• Reproduction Toxicology
  
• Juvenile Toxicology  
  
• Genetic Toxicology
  
• Ecotoxicology
  
• Physical Chemistry
  
• REACH Services
  
• Bio/Analytical Chemistry
  
• Medical Devices
  
• Wound Healing studies

VITROCELL© Systems GmbH
Mr. Tobias Krebs
Fabrik Sonntag 3, 79183 Waldkirch / Germany
Tel.:     +49 (0) 7681-24 100
Fax:    +49 (0) 7681-43 54
Mobile: +49 (0) 172-60 40 370
info@vitrocell.com
www.vitrocell.com

VITROCELL© is specialised in the development, manufacturing, sales and service of innovative cultivation and exposure systems for in vitro studies using cells or bacteria. VITROCELL© modules are specially designed for the analysis of gases, environmental atmospheres, nano particles and complex mixtures (e.g. cigarette smoke and diesel exhaust) at the air/liquid interface. The product program includes gas mixing devices, aerosol generators, dilution systems and equipment for dose control. All can be integrated in turnkey cultivation and exposure systems.
The customers of  VITROCELL©  are leading medical and environmental research institutes as well as pharmaceutical and other industries.

VIVOTECNIA
Parque Tecnológico de Madrid
28760 Tres Cantos
Madrid – España
e-mail: info@vivotecnia.com

Vivotecnia is a preclinical CRO specialized in Toxicology and PK for product registration according to international regulatory requirements. We offer a wide portfolio of studies under GLP standards, from rodents (mouse, rat, guinea pig) to larger animals (dog, mini pigs and sheep), through different administration routes: from commonly used (oral, intraperitoneal) to the more elaborated (inhalation or dermal) and up to different repeated dose durations.
We have extensive experience performing:

• Nose-only and whole-body inhalation studies in rats and mice.
• Dermal toxicity studies in rabbits and mini pigs.
• Ophthalmic toxicity studies in rabbits.
• Pharmacokinetics studies in mice, rats, dogs and mini pigs.
• Tumorigenesis for cell therapy.
• Behavior models such as Morris Water Maze and Object Recognition.
• Non-regulatory carcinogenesis studies (Skin carcinogenesis).

For further information please visit our website at: www.vivotecnia.com

WILEY
The Atrium Southern Gate Chichester West Sussex PO19 8SQ
www.wiley.com
amasmith@wiley.com

The Atrium, Southern Gate
Chichester, West Sussex PO19 8SQ
Visit booth #68 and discover Wiley’s latest books, major reference works and quality peer-reviewed journals .  Pick up free sample issues of Journal of Applied Toxicology (celebrating 30 years), Basic & Clinical Pharmacology & Toxicology, Journal of Biochemical and Molecular Toxicology, the 2009 launched journal, Drug Testing and Analysis, and more… Browse and buy at a 20% discount latest editions of General and Applied Toxicology,  A Textbook of Modern Toxicology, as well as Frontiers in Toxicology and Quantitative Modeling in Toxicology.

XENOMETRIX AG
Gewerbestrasse 25
4123 Allschwil
Switzerland
www.xenometrix.ch

With the collaboration for specific activities of:
AAALAC, CAAT, Eco Conseil, GREC CERETOX (UB/PCB), ECOPA, ECVAM, EFSA, JACVAM, Journal Editors, OpenTox, REMA (The Spanish Network of Alternative Methods),  US NLM, UN, WHO OECD.

Xenometrix offers the Ames MPF  assay kits for all strains required by the "OECD Guideline 471: TA98, TA100, TA1535, TA1537, E. coli WP2 uvrA, E. coli WP2 [pKM101]
The Ames MPF Kits kit include media, ampicillin, rat liver S9 (optional) and positive controls (optional). The assays are based on the fluctuation and pre-incubation method cited in the OECD Guideline 471, but use liquid media in microplates and have a colorimetric read-out.

Xenometrix also offers cytotoxicity kits with multiple endpoints for one cellular sample. Such an approach enhances the probability of identifying toxic compounds, uses less test compounds and removes inter-assay variability.